A follow-up study suggests that aspirin therapy does not reduce cancer risk in older adults, but may instead increase cancer-related mortality risk.

Researchers say that a daily routine of low-dose aspirin does not appear to reduce the risk of cancer in older adults.

Low-dose aspirin may limit cancer metastasis by inhibiting platelet activation and enhancing T-cell immunity, supporting biomarker guided use while balancing bleeding risk overall.

President Donald Trump has said on multiple occasions in recent months that he takes a “large” dose of aspirin to prevent cardiovascular disease. His comments could perpetuate a common misperception, ...

Millions of people take a daily low-dose aspirin, even though they are not at risk of heart disease. (Getty Images) For years, doctors recommended that older adults at a higher risk for heart attack ...

Taking a low-dose daily aspirin long term may reduce the risk of developing or dying from colorectal cancer by revving the body’s immune response to cancer cells, according to a new study published ...

Low-dose aspirin use is associated with a reduced risk for colorectal cancer (CRC), confirms a large-scale cohort study, which also suggests that the risk reduction is greatest for metastatic disease ...

Once widely seen as a harmless preventive measure, daily aspirin is now being reconsidered for people without underlying ...

Sign up for our FREE E-Weekly for more coverage like this sent to your inbox! For the study, researchers examined data on 86,206 women compiled in the Nurses ...

DEAR DR. ROACH: My wife and I are both healthy and in our 70s. At 5 feet, 9 inches tall, we are both at a reasonable weight. Our yearly blood panels always come back with good results. We both take ...

Researchers found that the cumulative incidence of MI, stroke, and 10-year all-cause mortality was significantly lower in the ASA group vs the no-ASA group (42.4 vs 61.2%, 14.5 vs 24.8%, and 33 vs ...